New Radioactive Therapy Shrinks Glioblastoma Tumor by Half in NHS Trial

A pioneering treatment at London Hospitals shows promise in combating aggressive brain cancer by targeting tumors with radioactive drugs.

Paul Read, a 62-year-old engineer, is the first patient to experience a 50% reduction in his glioblastoma tumor through the trial.
The treatment involves injecting a radioactive drug directly into the tumor, using an Ommaya reservoir implanted under the scalp.
Doctors plan to expand the trial, initially treating one patient a month, with hopes of increasing radiation doses and combining the therapy with immunotherapy.
The trial, designed by Dr. Paul Mulholland and sponsored by Ariceum Therapeutics, aims to offer a potentially curative approach for glioblastoma.
A separate study by the Institute of Cancer Research is exploring a new scan technique to better diagnose and monitor glioblastoma for personalized treatment plans.